TherapeuticsMD, Inc. (TXMD) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $3.02M | +71.6% |
| 2024 | $1.76M | +35.3% |
| 2023 | $1.30M | -98.1% |
| 2022 | $69.96M | +2619.1% |
| 2021 | $2.57M | -96.0% |
| 2020 | $64.87M | +30.7% |
| 2019 | $49.65M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $3.02M | +71.6% |
| 2024 | $1.76M | +35.3% |
| 2023 | $1.30M | -98.1% |
| 2022 | $69.96M | +2619.1% |
| 2021 | $2.57M | -96.0% |
| 2020 | $64.87M | +30.7% |
| 2019 | $49.65M | — |